|
Journal of Lipid Research, Vol 29, 1557-1571, Copyright © 1988 by Lipid Research, Inc.
Protein heterogeneity of lipoprotein particles containing apolipoprotein A-I without apolipoprotein A-II and apolipoprotein A-I with apolipoprotein A-II isolated from human plasma
RW James, D Hochstrasser, JD Tissot, M Funk, R Appel, F Barja, C Pellegrini, AF Muller and D Pometta
Division de Diabetologie, Hopital Cantonal Universitaire, Geneva, Switzerland.
The protein heterogeneity of fractions isolated by immunoaffinity
chromatography on anti-apolipoprotein A-I and anti-apolipoprotein A-II
affinity columns was analyzed by high resolution two-dimensional gel
electrophoresis. The two-dimensional gel electrophoresis profiles of the
fractions were analyzed and automatically compared by the computer system
MELANIE. Fractions containing apolipoproteins A-I + A-II and only A-I as
the major protein components have been isolated from plasma and from high
density lipoproteins prepared by ultracentrifugation. Similarities between
the profiles of the fractions, as indicated by two- dimensional gel
electrophoresis, suggested that those derived from plasma were equivalent
to those from high density lipoproteins (HDL), which are particulate in
nature. The established apolipoproteins (A-I, A-II, A-IV, C, D, and E) were
visible and enriched in fractions from both plasma and HDL. However,
plasma-derived fractions showed a much greater degree of protein
heterogeneity due largely to enrichment in bands corresponding to six
additional proteins. They were present in trace amounts in fractions
isolated from HDL and certain of the proteins were visible in
two-dimensional gel electrophoresis profiles of the plasma. These proteins
are considered to be specifically associated with the
immunoaffinity-isolated particles. They have been characterized in terms of
Mr and pI. Computer-assisted measurements of protein spot-staining
intensities suggest an asymmetric distribution of the proteins (as well as
the established apolipoproteins), with four showing greater prominence in
particles containing apolipoprotein A-I but no apolipoprotein A-II.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
X. Moren, S. Deakin, M.-L. Liu, M.-R. Taskinen, and R. W. James
HDL subfraction distribution of paraoxonase-1 and its relevance to enzyme activity and resistance to oxidative stress
J. Lipid Res.,
June 1, 2008;
49(6):
1246 - 1253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Movva and D. J. Rader
Laboratory Assessment of HDL Heterogeneity and Function
Clin. Chem.,
May 1, 2008;
54(5):
788 - 800.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. L. Anderson and N. G. Anderson
The Human Plasma Proteome: History, Character, and Diagnostic Prospects
Mol. Cell. Proteomics,
November 1, 2002;
1(11):
845 - 867.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Deakin, I. Leviev, M. Gomaraschi, L. Calabresi, G. Franceschini, and R. W. James
Enzymatically Active Paraoxonase-1 Is Located at the External Membrane of Producing Cells and Released by a High Affinity, Saturable, Desorption Mechanism
J. Biol. Chem.,
February 1, 2002;
277(6):
4301 - 4308.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Leviev, S. Deakin, and R. W. James
Decreased stability of the M54 isoform of paraoxonase as a contributory factor to variations in human serum paraoxonase concentrations
J. Lipid Res.,
April 1, 2001;
42(4):
528 - 535.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. N. Duchateau, C. R. Pullinger, M. H. Cho, C. Eng, and J. P. Kane
Apolipoprotein L gene family: tissue-specific expression, splicing, promoter regions; discovery of a new gene
J. Lipid Res.,
April 1, 2001;
42(4):
620 - 630.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. A. Deeg, E. L. Bierman, and M. C. Cheung
GPI-specific phospholipase D associates with an apoA-I- and apoA-IV-containing complex
J. Lipid Res.,
March 1, 2001;
42(3):
442 - 451.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. CANDIANO, L. MUSANTE, M. CARRARO, L. FACCINI, L. CAMPANACCI, C. ZENNARO, M. ARTERO, F. GINEVRI, F. PERFUMO, R. GUSMANO, et al.
Apolipoproteins Prevent Glomerular Albumin Permeability Induced In Vitro by Serum from Patients with Focal Segmental Glomerulosclerosis
J. Am. Soc. Nephrol.,
January 1, 2001;
12(1):
143 - 150.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Raper, R. Fung, J. Ghiso, V. Nussenzweig, and S. Tomlinson
Characterization of a Novel Trypanosome Lytic Factor from Human Serum
Infect. Immun.,
April 1, 1999;
67(4):
1910 - 1916.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. N. Duchateau, C. R. Pullinger, R. E. Orellana, S. T. Kunitake, J. Naya-Vigne, P. M. O'Connor, M. J. Malloy, and J. P. Kane
Apolipoprotein L, a New Human High Density Lipoprotein Apolipoprotein Expressed by the Pancreas. IDENTIFICATION, CLONING, CHARACTERIZATION, AND PLASMA DISTRIBUTION OF APOLIPOPROTEIN L
J. Biol. Chem.,
October 10, 1997;
272(41):
25576 - 25582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Deeg, R. F. Bowen, J. F. Oram, and E. L. Bierman
High Density Lipoproteins Stimulate Mitogen-Activated Protein Kinases in Human Skin Fibroblasts
Arterioscler. Thromb. Vasc. Biol.,
September 1, 1997;
17(9):
1667 - 1674.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. Lagrost, C. Dengremont, A. Athias, C. d. Geitere, J.-C. Fruchart, C. Lallemant, P. Gambert, and G. Castro
Modulation of Cholesterol Efflux from Fu5AH Hepatoma Cells by the Apolipoprotein Content of High Density Lipoprotein Particles
J. Biol. Chem.,
June 2, 1995;
270(22):
13004 - 13009.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1988 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|